Skip to search boxSkip to navigationSkip to main content

The first report of CADASIL in Peru: Olfactory dysfunction on initial presentation

  • Anastasia Vishnevetsky
    ,
  • Miguel Inca-Martinez
    ,
  • Karina Milla-Neyra
    ,
  • Danny Moises Barrientos-Iman
    ,
  • Ivan Cornejo-Herrera
    ,
  • Carlos Cosentino
  • Perelman School of Medicine at the University of Pennsylvania
    ,
  • docencia y atención especializada en epilepsia
    ,
  • North Pacific Fogarty Global Health Fellow
    ,
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 15-19 (5 pages)

Journal (Volume, Issue Number)

eNeurologicalSci (Volume 5)

Publication milestones

  • Published - 01/12/2016

Publication status

Published - 01/12/2016

Publication IDs

  • Scopus: 84993990849

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is a rare, heritable, small vessel vascular disease caused by mutations in the Notch3 gene that is characterized by migraines, subcortical vascular events, cognitive decline, and mood disturbances. However, many CADASIL cases present with unusual symptoms such as status epilepticus, a movement disorder, or sensory dysfunction. This study describes the clinical, genetic, and radiologic characteristics of a Peruvian family with CADASIL in which multiple family members presented with severe olfactory deficits. Seven members of the family have symptoms suggestive of CADASIL, with genetic testing revealing R133C mutations in the two patients who underwent genetic testing. Cognitive testing and olfactory identification testing (Smell Identification Test) were performed in three CADASIL patients revealing total anosmia in two tested patients and severe hyposmia in the other. Olfactory dysfunction has been associated with various neurologic and psychiatric conditions, though few studies have linked it with neurovascular disorders such as CADASIL. This first reported case of CADASIL in Peru emphasizes that symptomatic olfactory dysfunction may be an unusual presentation of CADASIL and that olfactory dysfunction is important to evaluate in CADASIL patients.

Funding Details

We thank all study participants and the physicians who referred patients. We thank Mario Velit-Salazar, Victoria Marca, Olimpio Ortega, Diana Salazar, and Pilar Mazzetti for their help and support. We thank the Laboratoire de Genetique Moleculaire of the Hôpital Lariboisiere in Paris for providing the CADASIL molecular diagnostics results. Special thanks to Sensonics Inc. for providing the Smell Identification Test kits and user guide. Research training for AV was supported by NIH Research Training Grant # R25 TW009345 funded by the Fogarty International Center , the NIH Office of the Director , Office of AIDS Research , the Office of Research on Women's Health , the National Heart, Lung, and Blood Institute , the National Institute of Mental Health and the National Institute of General Medical Sciences .
FundersFunding numbers
NIH
R25 TW009345
NIMH
-
NHLBI
-
OD
-
NIGMS
-
FIC
-
ORWH
-
OAR
-